Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity

Diabetologia

Volumn 38, Issue 7, 1995, Pages 816-822

  Bonifacio, E ^a   Genovese, S ^a   Braghi, S ^a   Bazzigaluppi, E ^a   Lampasona, Y ^a   Bingley, P J ^b   Rogge, L ^c   Pastore, M R ^a   Bognetti, E ^a   Bottazzo, G F ^b   Gale, E A M ^b   Bosi, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROCHE MILANO RICERCHE   (Italy)

Author keywords

carboxypeptidase H; glutamic acid decarboxylase65 antibodies; ICA69.; insulin dependent diabetes mellitus prediction; islet autoantigens; Islet cell antibodies

Indexed keywords

AUTOANTIBODY; CARBOXYPEPTIDASE H; GLUTAMATE DECARBOXYLASE;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; ETIOLOGY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE OF ONSET; ANIMAL; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; DIABETES MELLITUS, INSULIN-DEPENDENT; GLUTAMATE DECARBOXYLASE; HUMAN; INSULINOMA; ISLETS OF LANGERHANS; MIDDLE AGE; PANCREATIC NEOPLASMS; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; RATS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0029040544     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s001250050358     Document Type: Article

References (31)

1. Immune intervention in type 1 diabetes mellitus
2. Quantification of islet cell antibodies and prediction of insulin-dependent diabetes
3. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes
4. Natural history of preclinical IDDM in high risk siblings
5. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency
6. Progress towards standardization of cytoplasmic islet cell antibody assays
7. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies
8. Assessment of precision, concordance, specificity and sensitivity of islet cell antibody measurement in 41 assays
9. Improved specificity of ICA assays in the Fourth International Immunology of Diabetes serum exchange Workshop
10. An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM
11. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type I (insulin-dependent) diabetes mellitus in high risk individuals
12. Antibodies to glutamic acid decarboxylase as predictiors of insulin-dependent diabetes mellitus before clinical onset of disease
13. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody positive relatives
14. Combined analysis of IDDM-related autoantibodies in healthy schoolchildren
15. A novel radiobinding assay to determine diagnostic accuracy of iso-form-specific glutamic acid decarboxylase antibodies in childhood IDDM
16. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay
17. Autoantibodies in insulin-dependent diabetes mellitus
18. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment
19. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type 1 diabetes
20. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen
21. Purification of mRNA and DNA binding proteins using magnetic beads
22. Quantitation of mRNA by the polymerase chain reaction
23. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
24. Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on Western blots but do not immunoprecipitate liquid phase antigen
25. Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type 1 diabetic children
26. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus
27. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes
28. Islet cell antibody heterogeneity among type 1 (insulin-dependent) diabetic patients
29. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes
30. Antibodies to islet 37 k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity
31. Can we really predict IDDM?